2014
DOI: 10.1111/imm.12227
|View full text |Cite
|
Sign up to set email alerts
|

Role of miR‐155 in the regulation of lymphocyte immune function and disease

Abstract: MicroRNAs (miRNAs) have emerged as critical regulators of gene expression within cells. One particular miRNA, miR-155, is highly expressed within lymphocytes (both B and T cells) and mediates a number of important roles. These include shaping the transcriptome of lymphoid cells that control diverse biological functions vital in adaptive immunity. The use of mice engineered to be deficient in miR-155, as well as the identification of endogenous targets of miR-155 in T cells by transcriptome-wide analysis, has h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
122
0
3

Year Published

2015
2015
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 151 publications
(128 citation statements)
references
References 62 publications
3
122
0
3
Order By: Relevance
“…miR-155 has also been reported to regulate T cell trafficking and function (51)(52)(53). T cells have been shown to accumulate in the brain and to contribute to endothelial injury and death associated with ECM (54).…”
Section: Resultsmentioning
confidence: 99%
“…miR-155 has also been reported to regulate T cell trafficking and function (51)(52)(53). T cells have been shown to accumulate in the brain and to contribute to endothelial injury and death associated with ECM (54).…”
Section: Resultsmentioning
confidence: 99%
“…In addition, the potential therapeutic inhibition of miR-155 is hampered by the multifunctional role of this microRNA and could result in multiple unwanted side effects such as immunosuppression [39] and tumor growth [52].…”
Section: Limitations Of the Studymentioning
confidence: 99%
“…MiR-155 has been extensively described for its essential role in the normal immune function of B-cell and T-cell lymphocytes and dendritic cells, but also as a likely driver in some aggressive lymphomas such as Hodgkin's and diffuse large B-cell (Vigorito et al 2013;Seddiki et al 2014). It has been proposed that because miR-155 is oncogenic in lympho-proliferative disorders, this may be true for other cancers.…”
Section: Introductionmentioning
confidence: 99%